Find us on:

LDN Researchers

Distinguished Professor and Educator - Director of the Program on Education in Human Structure

Hershey Medical Center, Penn State University

Research areas:

LDN in animal models of cancer and Multiple Sclerosis; Mechanism of action of LDN in cancer, Multiple Sclerosis, Autoimmune Diseases, and Parkinson’s Disease.

Dr. Patricia J. McLaughlin, Ph.D.

Professor of Neural and Behavioral Sciences - Director of the Graduate Program in Anatomy

Hershey Medical Center, Penn State University

Research areas:

LDN in animal models of multiple sclerosis, multiple types of cancer, Parkinson’s disease and autoimmune disorders.

Moshe Rogosnitzky

Research Scientist
Innovator and Inventor

MedInsight Research Institute
Ariel University Center for Drug Repurposing

Research areas:

Clinical trials of LDN for Crohn’s Disease and liver cancer (hepatoblastoma).

Dr. Maira Gironi, M.D.

Institute of Experimental Neurology (INSPE) and Department of Neurology, San Raffaele Scientific Institute, Milan, Italy

Research areas:

Clinical trials of LDN for Multiple Sclerosis.

Dr. Sean Mackey, M.D., Ph.D.

Chief, Pain Management Division

Stanford University School of Medicine

Research areas:

Clinical trials of LDN for Fibromyalgia and CRPS.

Dr. Jill P. Smith, M.D.

Emeritus Professor of Medicine

Hershey Medical Center, Penn State University

Research areas:

Clinical trials of LDN for Crohn's Disease in adults and in children.

Dr. Leonard Weinstock, M.D.

President of Specialists in Gastroentrology; Associate Professor of Clinical Medicine and Surgery

Washington University School of Medicine

Research areas:

LDN efficacy and side effects in gastrointestinal disorders; LDN efficacy in Crohn’s Disease, Ulcerative Colitis, Restless Leg Syndrome, Sarcoidosis, and CRPS.

Dr. Jarred Younger, Ph.D.

Associate Professor, Director of the NeuroInflammation, Pain, and Fatigue Laboratory

University of Alabama at Birmingham School of Medicine

Research areas:

Clinical trials of LDN for Fibromyalgia; Mechanism of action of LDN in neuroinflammation.

Prof. Angus Dalgleish, M.D., F.R.C.P., F.R.A.C.P., F.R.C.Path, F.Med.Sci

Professor of Medical Oncology (St George's University of London), Consultant Physician (St George's Hospital)

St George's University of LondonSt George's Hospital

Research areas:

LDN as an adjuvant therapy for cancer.

Dr. Burton Berkson, M.D., M.S., Ph.D.

President, Integrative Medical Center; Adjunct Professor

Integrative Medical Center
New Mexico State University
Oklahoma State University College of Medicine

Research areas:

LDN (and combination LDN plus alpha lipoic acid) for cancer (including pancreatic cancer) and autoimmune disease, especially rheumatoid arthritis and systemic lupus erythematosus (lupus).

Display #

About LDNscience^®
LDNscience^® is a public information project of the MedInsight^® Research Institute.

MedInsight^® Research Institute is a U.S./U.K. based non-profit organization which serves as a platform for researching and indexing available off-label (repurposed) treatments for cancer and chronic diseases.